Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 46

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 8
Chunk 46
---
    $69,642 

Future minimum lease liability payments under
the non-cancelable operating lease at March 31, 2025 and December 31, 2024 are as follows:

Schedule
of Future Minimum Lease Liability Payments Under Non-cancelable Operating Lease

    2025 
    $38,073  
    $50,476 
  
    2026 
     21,290  
     21,290 
  
    Total lease payments 
     59,363  
     71,766 
  
    Less: imputed interest 
     (300) 
     (437)
  
    Total lease liabilities 
    $59,063  
    $71,329 

    Current operating lease liabilities 
     50,556  
     50,082 
  
    Non-current operating lease liabilities 
     8,507  
     21,247 
  
    Total lease liabilities 
    $59,063  
    $71,329 

    21

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 7 – Commitments and Contingencies,
continued

Office Lease, continued

Lease expense related to leases with an
initial period of less than twelve months is expensed as incurred. Such short-term rental expense totaled $2,029 and
$4,210 for the three months ended March 31, 2025 and 2024, respectively, and is included in general and administrative expenses on the accompanying
condensed consolidated statements of operations.

Consulting Agreements

The Company utilizes various consultants and advisors
for clinical research, scientific advisory services and business strategies. Each consultant has an executed agreement in place defining
term, compensation, duties, confidentiality, intellectual property. The majority of the agreements have a 2-year term. Agreements are
evaluated for renewal upon expiration. Bonus provisions are at the discretion of the Company’s Board of Directors and are granted
on an individual agreement basis.

On December 15, 2024, the Company entered into
a Strategic Services Agreement (the “Dominant Treasure Agreement”) with Dominant Treasure Health Company Limited (“Dominant
Treasure”). Pursuant to the terms of the Dominant Treasure Agreement, Dominant Treasure agreed to provide certain services to the
Company to assist the Company in accelerating the Company’s desire to get its